Medisca's Hair Care Compounding Solutions

Download in electronic PDF format for $25

Search the Complete Journal Archives

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada

Author(s):  Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise

Issue:  Jul/Aug 2008 - Hormone Replacement Therapy
View All Articles in Issue

Abstract:  There are a limited number of commercial oral pediatric drug formulations on the market. The incidence of available commercial oral formulations for children has not been studied to date. This study compared the number and the characteristics of oral pediatric drug formulations listed on two hospital group purchasing agreements for the two large urban areas (e.g., Paris and Montreal), valid on April 1, 2006. Variables collected were the brand and the generic name product, the anatomical therapeutic chemical classification, the drug formulation, and the dispensing tool. Throughout this study, we identified that there was a total of 191 and 151 commercial oral pediatric drug formulations corresponding to 127 and 94 generic name products, respectively in Paris and Montreal. The three main anatomical therapeutic chemical classification classes are alimentary tract and metabolism drugs, systemic anti-infectives, and drugs acting on nervous system. There are only 47 generic names common to both group purchasing agr

Related Keywords: Sonia Prof-LaBarthe, DPharm, PhD, Jean-Francois Bussieres, BPharm, MSc, MBA, CSHP, Pierre Barret, Olivier Bourdon, DPharm, PhD, MBA, Francoise Brion, DPharm, PhD, children, hospital pharmacy, oral formulations, Canada, France, dosage forms


Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise Jul/Aug 2008 365-367 Buy
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials Storme-Paris Isabelle, Storme Thomas, Thauvin Maxime, Brion Francoise, Chaminade Pierre, Rieutord Andre Jan/Feb 2009 81-86 Buy
Room Temperature Stability of Injectable Succinylcholine Dichloride Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice Jan/Feb 2008 83-85 Buy
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin May/Jun 2015 261-267 Buy
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives Palmeira-de-Oliveira Rita, Macedo Marina, Machado Rita M, Pacheco Ana Filipa, Palmeira-de-Oliveira Ana, Martinez-de-Oliveira José, Duarte Paulo Mar/Apr 2016 114-122 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese May/Jun 2009 250-253 Buy
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R Sep/Oct 2012 431-433 Buy
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid Gupta Vishnu D, Ling Jie May/Jun 2001 232-233 Buy
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice Sep/Oct 2011 428-434 Buy